{"gene":"MMADHC","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2008,"finding":"MMADHC (cblD gene) was identified as responsible for the cblD defect of vitamin B12 metabolism. The predicted protein contains a putative cobalamin binding motif and a putative mitochondrial targeting sequence with sequence homology to bacterial ATP-binding cassette transporters. Transfection of wild-type MMADHC rescued adenosylcobalamin and methylcobalamin synthesis in cblD fibroblasts, confirming its essential role in intracellular cobalamin metabolism.","method":"Microcell-mediated chromosome transfer, genetic mapping, transfection rescue assays in patient fibroblasts, mutant construct analysis","journal":"The New England Journal of Medicine","confidence":"High","confidence_rationale":"Tier 1–2 — functional rescue, multiple mutant constructs, replicated across multiple patients; foundational discovery paper with 122 citations","pmids":["18385497"],"is_preprint":false},{"year":2004,"finding":"The cblD defect can cause three distinct biochemical phenotypes: isolated homocystinuria (cblD-variant 1, deficient methylcobalamin synthesis), isolated methylmalonic aciduria (cblD-variant 2, deficient adenosylcobalamin synthesis), or combined deficiency, demonstrating that MMADHC acts at a branch point affecting both cytosolic (MeCbl) and mitochondrial (AdoCbl) cobalamin pathways.","method":"Complementation analysis, cell culture biochemical assays measuring cobalamin derivative synthesis in patient fibroblasts","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 — complementation analysis across multiple patient lines replicated in multiple independent labs; 96 citations","pmids":["15292234"],"is_preprint":false},{"year":2008,"finding":"Mutations affecting the N-terminus of MMADHC are associated with methylmalonic aciduria (AdoCbl deficiency), while mutations affecting the C-terminus are associated with homocystinuria (MeCbl deficiency), indicating distinct functional domains within MMADHC for mitochondrial versus cytoplasmic cobalamin trafficking.","method":"MMADHC gene sequence analysis in patient DNA, complementation analysis, fibroblast biochemical assays","journal":"The Journal of Pediatrics","confidence":"Medium","confidence_rationale":"Tier 2 — genotype-phenotype correlation across multiple patients, consistent with functional domain model","pmids":["19058814"],"is_preprint":false},{"year":2010,"finding":"MMADHC physically interacts with MMACHC (cblC protein) both in vitro and in vivo. MMACHC binds cobalamin derivatives with low micromolar affinities, and five putative MMACHC-binding sites on MMADHC were identified by phage display, confirmed by surface plasmon resonance (SPR) and bacterial two-hybrid system.","method":"Phage display, surface plasmon resonance (SPR), bacterial two-hybrid system, dynamic light scattering, intrinsic fluorescence","journal":"Molecular Genetics and Metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal in vitro and in vivo binding assays; replicated in subsequent studies","pmids":["21071249"],"is_preprint":false},{"year":2011,"finding":"MMADHC has two distinct functional domains: the sequence after Met116 is sufficient for MeCbl synthesis (cytoplasmic function), while the additional sequence between Met62 and Met116 is required for AdoCbl synthesis (mitochondrial function). Improving mitochondrial targeting of MMADHC increased AdoCbl with concomitant decrease in MeCbl, establishing MMADHC as a branch point in intracellular cobalamin trafficking. Mutations N-terminal to Met116 causing cblD-MMA phenotype can produce truncated proteins via downstream reinitiation of translation.","method":"Transfection of MMADHC expression constructs with modified mitochondrial leader sequences, stop codon mutations, and downstream reinitiation site mutations into patient fibroblasts; western blot analysis; AdoCbl and MeCbl synthesis assays","journal":"Human Molecular Genetics","confidence":"High","confidence_rationale":"Tier 1–2 — systematic mutagenesis across multiple constructs and multiple patient cell lines with quantitative biochemical readouts","pmids":["22156578"],"is_preprint":false},{"year":2012,"finding":"MMADHC is localized both in the cytoplasm and mitochondria (dual subcellular localization), while MMACHC is exclusively cytoplasmic, as determined by immunofluorescence and subcellular fractionation. This dual localization is consistent with MMADHC functioning as a branch point for vitamin B12 delivery to both cytoplasmic (MeCbl) and mitochondrial (AdoCbl) pathways.","method":"Immunofluorescence, subcellular fractionation, retroviral expression of GFP-tagged constructs with functional complementation assays","journal":"Molecular Genetics and Metabolism","confidence":"High","confidence_rationale":"Tier 2 — direct localization by two independent methods with functional consequence demonstrated by complementation","pmids":["23270877"],"is_preprint":false},{"year":2012,"finding":"Recombinant MMADHC is monomeric, adopts an extended conformation in solution with significant disorder in the N-terminal domain, and does not bind cobalamin directly. The structured C-terminal domain mediates MMACHC interaction with sub-micromolar affinity, stronger than MMACHC self-association.","method":"Recombinant protein expression and purification, dynamic light scattering, circular dichroism, clear-native PAGE, phage display, SPR","journal":"Molecular Genetics and Metabolism","confidence":"High","confidence_rationale":"Tier 1 — multiple biophysical methods characterizing structure and interaction; no cobalamin binding detected by direct assay","pmids":["22832074"],"is_preprint":false},{"year":2013,"finding":"MMADHC (CblD) functions downstream of MMACHC (CblC) in the cobalamin trafficking pathway. The C-terminal domain of MMADHC interacts with CblC, and this complex forms preferentially under conditions permitting dealkylation of alkylcobalamin by CblC or in the presence of hydroxocobalamin (the dealkylated product), suggesting MMADHC acts as an adapter that partitions the cofactor between AdoCbl and MeCbl assimilation pathways. The N-terminal 115 residues are not required for the CblC–CblD interaction.","method":"Isolation of CblC·CblD complex under defined cobalamin substrate conditions, analysis of N-terminal truncation variants, limited proteolysis mapping of stable C-terminal domain, fibroblast dealkylation assays","journal":"Biochimie","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal approaches including complex isolation under defined conditions and functional cell assays","pmids":["23415655"],"is_preprint":false},{"year":2014,"finding":"Mutagenesis mapping identified a region spanning approximately p.R197–D226 of MMADHC as responsible for MeCbl synthesis, with additional flanking regions (p.D226–D246 and p.L259–R266) contributing intermediate phenotypes. C-terminal truncations of more than 20 amino acids produce a combined MMA/HC phenotype, while truncations of 10–20 amino acids produce isolated HC phenotype, defining precise domain boundaries for cytoplasmic versus combined cobalamin trafficking functions.","method":"Site-directed mutagenesis (15 missense and 5 C-terminal truncations), transfection rescue assays measuring AdoCbl and MeCbl synthesis in immortalized cblD-MMA/HC patient fibroblasts","journal":"Journal of Inherited Metabolic Disease","confidence":"High","confidence_rationale":"Tier 1–2 — systematic mutagenesis across 20 constructs with quantitative biochemical readouts in patient cells","pmids":["24722857"],"is_preprint":false},{"year":2015,"finding":"Crystal structure of the MMADHC C-terminal domain at 2.2 Å resolution reveals a modified nitroreductase fold with structural homology to MMACHC despite poor sequence conservation. MMADHC demonstrates no enzymatic activity and is proposed as the first protein to repurpose the nitroreductase fold solely for protein-protein interaction. The MMACHC-MMADHC complex is a 1:1 heterodimer (by SAXS), with the interaction region overlapping the MMACHC-cobalamin binding site, indicating cobalamin is processed by MMACHC prior to interaction with MMADHC. Disease-causing mutations on both proteins disrupt complex formation.","method":"X-ray crystallography (2.2 Å), small angle X-ray scattering (SAXS), interaction mapping by mutagenesis, analysis of disease-causing mutations","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus SAXS plus functional mutagenesis in a single study","pmids":["26483544"],"is_preprint":false},{"year":2015,"finding":"The crystal structure of the globular C-terminal domain of human CblD (MMADHC) reveals an α+β fold belonging to the nitro-FMN reductase superfamily, with closest structural relatives being CblC and the activation domain of methionine synthase. CblD enhances oxidation of cob(II)alamin bound to CblC, and disease-causing mutations in CblD impair the kinetics of this reaction, suggesting a functional role in cobalamin redox chemistry at the CblC interface.","method":"X-ray crystallography, kinetic assays for cob(II)alamin oxidation, analysis of disease-causing mutant kinetics","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with enzymatic/kinetic assays and disease mutation analysis","pmids":["26364851"],"is_preprint":false},{"year":2016,"finding":"MMADHC interacts with methionine synthase (MS) and methionine synthase reductase (MSR) in addition to its known interaction with MMACHC, forming a multiprotein complex (MS, MSR, MMACHC, MMADHC) in the cytoplasm. Disruption of MS or MMACHC expression perturbs interactions among all interactome members. This complex is proposed to shuttle cobalamin efficiently toward MS.","method":"Co-immunoprecipitation, DuoLink proximity ligation assays in patient fibroblasts (cblG, cblE, cblC) and HepG2 cells with siRNA knockdown","journal":"Biochimica et Biophysica Acta — Molecular Basis of Disease","confidence":"Medium","confidence_rationale":"Tier 2–3 — reciprocal co-IP and proximity ligation from single lab; interaction with MS/MSR not yet independently replicated","pmids":["27771510"],"is_preprint":false},{"year":2021,"finding":"Disease-associated premature termination codon (PTC) mutations in MMADHC differentially affect alternative translation initiation site usage, protein abundance, and subcellular localization of MMADHC. Aminoglycoside compounds induced translational PTC readthrough allowing biosynthesis of full-length MMADHC in a PTC-specific manner, suggesting potential for readthrough-based therapy.","method":"Characterization of MMADHC protein variants from PTC mutations, subcellular localization analysis, aminoglycoside-induced translational readthrough assays","journal":"Molecular Genetics and Metabolism Reports","confidence":"Medium","confidence_rationale":"Tier 2 — systematic characterization of multiple variants with functional localization readout from single lab","pmids":["33552904"],"is_preprint":false},{"year":2022,"finding":"CblD (MMADHC) reacts with CblC-bound cob(II)alamin forming an interprotein thiolato-cobalt coordination complex and transfers the cofactor to methionine synthase, though the precise mechanism of transfer remains to be elucidated.","method":"Enzymatic assays described in methods review chapter; biochemical characterization of chaperone activities","journal":"Methods in Enzymology","confidence":"Medium","confidence_rationale":"Tier 2 — biochemical characterization supporting interprotein thiolato-cobalt complex, but mechanism of transfer incompletely resolved; single review/methods chapter","pmids":["35589192"],"is_preprint":false},{"year":2025,"finding":"Mitochondrial membrane potential (proton motive force, PMF) collapse stabilizes MMADHC in the cytosol due to mitochondrial import failure, and this cytosol-stabilized MMADHC increases methionine synthase (MTR) levels and activity. MMADHC is normally short-lived; its levels increase upon PMF collapse prior to PINK1 activation, indicating MMADHC is a sensitive sensor linking mitochondrial status to cytosolic one-carbon metabolism.","method":"Joint proteomic and RNA-seq screen, subcellular fractionation, LONP1 inhibition, PMF collapse experiments, MTR activity assays across cell types","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (proteomics, fractionation, activity assays) but preprint not yet peer-reviewed","pmids":["41509439"],"is_preprint":true},{"year":2025,"finding":"Cryo-EM structures of human methionine synthase (MTR) in apo and cobalamin-bound states show that apo MTR adopts a conformation where the two halves act independently, with the C-half posed to bind cobalamin. AlphaFold predictions validated by interaction studies show MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading into MTR.","method":"Cryo-electron microscopy, AlphaFold structure prediction validated by interaction assays","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1–2 — cryo-EM structure with interaction validation, but preprint and AlphaFold predictions require independent experimental confirmation","pmids":["bio_10.1101_2025.11.10.687659"],"is_preprint":true}],"current_model":"MMADHC (CblD) is a dual-localized (cytoplasmic and mitochondrial) cobalamin trafficking chaperone that acts downstream of MMACHC (CblC) at a branch point in intracellular vitamin B12 metabolism: its C-terminal domain (adopting a nitroreductase fold) interacts with CblC-bound cob(II)alamin to form an interprotein thiolato-cobalt complex and partitions the cofactor between cytosolic methylcobalamin (MeCbl) synthesis for methionine synthase and mitochondrial adenosylcobalamin (AdoCbl) synthesis for methylmalonyl-CoA mutase, with distinct N-terminal and C-terminal regions governing these respective functions, and its stability and cytosolic localization are regulated by mitochondrial membrane potential to modulate methionine synthase activity."},"narrative":{"teleology":[{"year":2004,"claim":"Complementation analysis revealed that a single genetic locus (cblD) can produce three distinct biochemical phenotypes—isolated homocystinuria, isolated methylmalonic aciduria, or combined deficiency—establishing that the cblD gene product acts at a branch point directing cobalamin to both cytosolic and mitochondrial pathways.","evidence":"Complementation analysis and cobalamin derivative synthesis assays in multiple patient fibroblast lines","pmids":["15292234"],"confidence":"High","gaps":["Gene identity not yet determined","Mechanism of branch-point decision unknown"]},{"year":2008,"claim":"Positional cloning identified MMADHC as the cblD gene, and wild-type cDNA rescued both adenosylcobalamin and methylcobalamin synthesis in patient cells, while genotype–phenotype correlations showed that N-terminal mutations cause methylmalonic aciduria and C-terminal mutations cause homocystinuria, revealing domain-specific functions.","evidence":"Microcell-mediated chromosome transfer, genetic mapping, transfection rescue in patient fibroblasts, and mutation analysis across multiple cblD patients","pmids":["18385497","19058814"],"confidence":"High","gaps":["Whether MMADHC binds cobalamin directly was unknown","Structural basis for domain-specific functions unresolved"]},{"year":2010,"claim":"The demonstration that MMADHC physically interacts with MMACHC via multiple binding sites, confirmed by orthogonal methods, established MMADHC as a direct downstream partner of the CblC processing enzyme rather than an independent cobalamin-binding protein.","evidence":"Phage display, surface plasmon resonance, and bacterial two-hybrid assays with recombinant proteins","pmids":["21071249"],"confidence":"High","gaps":["Cobalamin-dependence of the interaction not yet tested","Stoichiometry of the complex unresolved"]},{"year":2011,"claim":"Systematic domain-swapping experiments defined Met116 as the boundary: sequence downstream of Met116 suffices for methylcobalamin synthesis, while the region between Met62 and Met116 is additionally required for adenosylcobalamin production, with enhanced mitochondrial targeting increasing AdoCbl at the expense of MeCbl—directly demonstrating MMADHC as the branch-point regulator.","evidence":"Transfection of modified MMADHC constructs with altered mitochondrial leader sequences and downstream reinitiation sites into patient fibroblasts, with quantitative AdoCbl/MeCbl synthesis assays","pmids":["22156578"],"confidence":"High","gaps":["How subcellular partitioning is regulated physiologically was unknown","Whether reinitiation of translation at Met116 is a general mechanism in vivo was unclear"]},{"year":2012,"claim":"Biophysical characterization showed MMADHC is a monomer with a disordered N-terminal domain and a structured C-terminal domain that mediates MMACHC binding with sub-micromolar affinity, and importantly that MMADHC does not bind cobalamin directly, confirming it functions as an adaptor rather than a carrier.","evidence":"Recombinant protein purification, dynamic light scattering, circular dichroism, clear-native PAGE, SPR; dual localization confirmed by immunofluorescence and subcellular fractionation","pmids":["22832074","23270877"],"confidence":"High","gaps":["Atomic-resolution structure not yet available","How cobalamin is transferred from MMACHC through MMADHC to downstream enzymes unresolved"]},{"year":2013,"claim":"Isolation of the MMACHC–MMADHC complex under defined cobalamin conditions showed that complex formation is favored after MMACHC-mediated dealkylation, establishing that MMADHC acts downstream of the CblC processing step and receives already-dealkylated cobalamin.","evidence":"Complex isolation under defined cobalamin substrate conditions, limited proteolysis, fibroblast dealkylation assays","pmids":["23415655"],"confidence":"High","gaps":["Fate of cofactor after MMADHC interaction still unresolved","Molecular basis for preferential complex formation with dealkylated cobalamin unclear"]},{"year":2014,"claim":"Fine-resolution mutagenesis mapped the MeCbl-specific function to residues ~R197–D226 and showed that progressive C-terminal truncations shift the phenotype from isolated homocystinuria to combined MMA/HC deficiency, defining precise domain boundaries for cytoplasmic cobalamin trafficking.","evidence":"15 missense and 5 C-terminal truncation constructs tested by transfection rescue in immortalized cblD fibroblasts","pmids":["24722857"],"confidence":"High","gaps":["No structural interpretation of how these residues participate in MeCbl-specific function","Residues required for mitochondrial AdoCbl function not systematically mapped at this resolution"]},{"year":2015,"claim":"Crystal structures of the MMADHC C-terminal domain revealed a nitroreductase fold homologous to MMACHC despite negligible sequence similarity, and SAXS confirmed a 1:1 heterodimer with MMACHC where the interaction surface overlaps the cobalamin-binding site; kinetic assays showed CblD enhances oxidation of CblC-bound cob(II)alamin, with disease mutations impairing this reaction.","evidence":"X-ray crystallography at 2.2 Å resolution, SAXS, mutagenesis of disease-causing variants, kinetic assays for cob(II)alamin oxidation","pmids":["26483544","26364851"],"confidence":"High","gaps":["No structure of the full-length MMADHC including the disordered N-terminal domain","Structural basis for how cobalamin is handed off to methionine synthase or mitochondrial pathway unknown"]},{"year":2016,"claim":"Co-immunoprecipitation and proximity ligation assays identified MMADHC as part of a cytoplasmic multiprotein complex with methionine synthase, methionine synthase reductase, and MMACHC, suggesting a channeling mechanism for cobalamin delivery to methionine synthase.","evidence":"Co-IP and DuoLink proximity ligation in patient fibroblasts and HepG2 cells with siRNA knockdown","pmids":["27771510"],"confidence":"Medium","gaps":["Interaction with MS/MSR not independently replicated","Stoichiometry and architecture of the multiprotein complex unresolved","Whether the complex is constitutive or regulated is unknown"]},{"year":2022,"claim":"Biochemical characterization confirmed that MMADHC forms an interprotein thiolato-cobalt coordination complex with MMACHC-bound cob(II)alamin and can transfer the cofactor to methionine synthase, establishing the chemical nature of the hand-off intermediate.","evidence":"Enzymatic assays characterizing chaperone activities of the CblC–CblD complex","pmids":["35589192"],"confidence":"Medium","gaps":["Precise mechanism of cofactor transfer to methionine synthase not elucidated","Whether a similar coordination complex forms during mitochondrial AdoCbl delivery is unknown"]},{"year":2025,"claim":"Proteomic and functional studies showed that mitochondrial membrane potential collapse stabilizes MMADHC in the cytosol (due to import failure), which in turn increases methionine synthase protein levels and activity—revealing MMADHC as a sensor linking mitochondrial status to cytosolic one-carbon metabolism. Separately, cryo-EM structures of apo methionine synthase showed MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading.","evidence":"Joint proteomic/RNA-seq screen, subcellular fractionation, PMF collapse experiments, MTR activity assays (preprint); cryo-EM of MTR with AlphaFold-guided interaction mapping (preprint)","pmids":["41509439","bio_10.1101_2025.11.10.687659"],"confidence":"Medium","gaps":["Both studies are preprints awaiting peer review","Structural details of MMADHC–apo MTR interface require experimental validation beyond AlphaFold","Whether MMADHC sensing of mitochondrial status is relevant in vivo under physiological stress is untested"]},{"year":null,"claim":"The mechanism by which MMADHC partitions cobalamin between the mitochondrial adenosylcobalamin and cytosolic methylcobalamin pathways—including the signals governing this decision, the structural basis for cofactor hand-off to methionine synthase and to the mitochondrial import machinery, and the physiological regulation of MMADHC partitioning in vivo—remains incompletely understood.","evidence":"","pmids":[],"confidence":"High","gaps":["No structure of full-length MMADHC or its complex with a downstream target","Mechanism of cobalamin transfer to methylmalonyl-CoA mutase in mitochondria uncharacterized","In vivo regulation of the branch-point decision is unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[6,7,9,13]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[10,14]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[4,5,14]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[4,5]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,1,4,8]}],"complexes":["MMACHC-MMADHC heterodimer"],"partners":["MMACHC","MTR","MTRR"],"other_free_text":[]},"mechanistic_narrative":"MMADHC (CblD) is a cobalamin trafficking chaperone that operates at the branch point of intracellular vitamin B12 metabolism, partitioning the cofactor between cytosolic methylcobalamin synthesis for methionine synthase and mitochondrial adenosylcobalamin synthesis for methylmalonyl-CoA mutase [PMID:15292234, PMID:22156578]. Its structured C-terminal domain adopts a nitroreductase fold that mediates a 1:1 interaction with MMACHC (CblC)-bound cob(II)alamin, forming an interprotein thiolato-cobalt complex through which the cofactor is transferred downstream, while the disordered N-terminal region harbors the mitochondrial targeting sequence required for adenosylcobalamin production [PMID:26483544, PMID:26364851, PMID:35589192]. MMADHC is dually localized to the cytoplasm and mitochondria; its cytosolic abundance is regulated by mitochondrial membrane potential, linking mitochondrial status to methionine synthase activity and one-carbon metabolism [PMID:23270877, PMID:41509439]. Biallelic loss-of-function mutations in MMADHC cause the cblD defect of vitamin B12 metabolism, manifesting as isolated methylmalonic aciduria, isolated homocystinuria, or combined disease depending on whether mutations disrupt the N-terminal or C-terminal functional domain [PMID:18385497, PMID:19058814]."},"prefetch_data":{"uniprot":{"accession":"Q9H3L0","full_name":"Cobalamin trafficking protein CblD","aliases":["CblD","Methylmalonic aciduria and homocystinuria type D protein, mitochondrial"],"length_aa":296,"mass_kda":32.9,"function":"Involved in cobalamin metabolism and trafficking (PubMed:18385497, PubMed:23415655, PubMed:24722857, PubMed:26364851). Plays a role in regulating the biosynthesis and the proportion of two coenzymes, methylcob(III)alamin (MeCbl) and 5'-deoxyadenosylcobalamin (AdoCbl) (PubMed:18385497, PubMed:23415655, PubMed:24722857). Promotes oxidation of cob(II)alamin bound to MMACHC (PubMed:26364851). The processing of cobalamin in the cytosol occurs in a multiprotein complex composed of at least MMACHC, MMADHC, MTRR (methionine synthase reductase) and MTR (methionine synthase) which may contribute to shuttle safely and efficiently cobalamin towards MTR in order to produce methionine (PubMed:27771510)","subcellular_location":"Cytoplasm; Mitochondrion","url":"https://www.uniprot.org/uniprotkb/Q9H3L0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MMADHC","classification":"Not Classified","n_dependent_lines":8,"n_total_lines":1208,"dependency_fraction":0.006622516556291391},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MMADHC","total_profiled":1310},"omim":[{"mim_id":"620953","title":"METHYLMALONIC ACIDURIA, cblD TYPE; MACD","url":"https://www.omim.org/entry/620953"},{"mim_id":"620952","title":"HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, cblD TYPE; HMAD","url":"https://www.omim.org/entry/620952"},{"mim_id":"611935","title":"METABOLISM OF COBALAMIN ASSOCIATED D; MMADHC","url":"https://www.omim.org/entry/611935"},{"mim_id":"277410","title":"METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblD TYPE; MAHCD","url":"https://www.omim.org/entry/277410"},{"mim_id":"251000","title":"METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-CoA MUTASE DEFICIENCY; MAMM","url":"https://www.omim.org/entry/251000"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MMADHC"},"hgnc":{"alias_symbol":["CL25022","cblD"],"prev_symbol":["C2orf25"]},"alphafold":{"accession":"Q9H3L0","domains":[{"cath_id":"-","chopping":"10-24_141-293","consensus_level":"high","plddt":92.271,"start":10,"end":293}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H3L0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3L0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H3L0-F1-predicted_aligned_error_v6.png","plddt_mean":76.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MMADHC","jax_strain_url":"https://www.jax.org/strain/search?query=MMADHC"},"sequence":{"accession":"Q9H3L0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H3L0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H3L0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H3L0"}},"corpus_meta":[{"pmid":"18385497","id":"PMC_18385497","title":"Gene identification for the cblD defect of vitamin B12 metabolism.","date":"2008","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18385497","citation_count":122,"is_preprint":false},{"pmid":"15292234","id":"PMC_15292234","title":"The cblD defect causes either isolated or combined deficiency of methylcobalamin and adenosylcobalamin synthesis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15292234","citation_count":96,"is_preprint":false},{"pmid":"22156578","id":"PMC_22156578","title":"Molecular mechanisms leading to three different phenotypes in the cblD defect of intracellular cobalamin metabolism.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22156578","citation_count":41,"is_preprint":false},{"pmid":"21071249","id":"PMC_21071249","title":"Interaction between MMACHC and MMADHC, two human proteins participating in intracellular vitamin B₁₂ metabolism.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21071249","citation_count":39,"is_preprint":false},{"pmid":"26483544","id":"PMC_26483544","title":"Structural Insights into the MMACHC-MMADHC Protein Complex Involved in Vitamin B12 Trafficking.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26483544","citation_count":39,"is_preprint":false},{"pmid":"23415655","id":"PMC_23415655","title":"The C-terminal domain of CblD interacts with CblC and influences intracellular cobalamin partitioning.","date":"2013","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/23415655","citation_count":34,"is_preprint":false},{"pmid":"19058814","id":"PMC_19058814","title":"Clinical and molecular heterogeneity in patients with the cblD inborn error of cobalamin metabolism.","date":"2008","source":"The Journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/19058814","citation_count":34,"is_preprint":false},{"pmid":"27771510","id":"PMC_27771510","title":"Methionine synthase and methionine synthase reductase interact with MMACHC and with MMADHC.","date":"2016","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/27771510","citation_count":29,"is_preprint":false},{"pmid":"22832074","id":"PMC_22832074","title":"Structural features of recombinant MMADHC isoforms and their interactions with MMACHC, proteins of mammalian vitamin B12 metabolism.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/22832074","citation_count":29,"is_preprint":false},{"pmid":"26364851","id":"PMC_26364851","title":"Structure of Human B12 Trafficking Protein CblD Reveals Molecular Mimicry and Identifies a New Subfamily of Nitro-FMN Reductases.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26364851","citation_count":22,"is_preprint":false},{"pmid":"23270877","id":"PMC_23270877","title":"Subcellular location of MMACHC and MMADHC, two human proteins central to intracellular vitamin B(12) metabolism.","date":"2012","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23270877","citation_count":22,"is_preprint":false},{"pmid":"24722857","id":"PMC_24722857","title":"Characterization of functional domains of the cblD (MMADHC) gene product.","date":"2014","source":"Journal of inherited metabolic disease","url":"https://pubmed.ncbi.nlm.nih.gov/24722857","citation_count":15,"is_preprint":false},{"pmid":"21536470","id":"PMC_21536470","title":"Expression of Mmachc and Mmadhc during mouse organogenesis.","date":"2011","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/21536470","citation_count":12,"is_preprint":false},{"pmid":"25155779","id":"PMC_25155779","title":"Clinical, Biochemical, and Molecular Presentation in a Patient with the cblD-Homocystinuria Inborn Error of Cobalamin Metabolism.","date":"2014","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/25155779","citation_count":12,"is_preprint":false},{"pmid":"23686626","id":"PMC_23686626","title":"Severe Neonatal Metabolic Decompensation in Methylmalonic Acidemia Caused by CblD Defect.","date":"2013","source":"JIMD reports","url":"https://pubmed.ncbi.nlm.nih.gov/23686626","citation_count":9,"is_preprint":false},{"pmid":"35589192","id":"PMC_35589192","title":"The human B12 trafficking chaperones: CblA, ATR, CblC and CblD.","date":"2022","source":"Methods in enzymology","url":"https://pubmed.ncbi.nlm.nih.gov/35589192","citation_count":6,"is_preprint":false},{"pmid":"1676355","id":"PMC_1676355","title":"Metabolic cooperation among cell lines from patients with inborn errors of vitamin B12 metabolism: differential response of cblC and cblD.","date":"1991","source":"Clinical and investigative medicine. Medecine clinique et experimentale","url":"https://pubmed.ncbi.nlm.nih.gov/1676355","citation_count":5,"is_preprint":false},{"pmid":"33552904","id":"PMC_33552904","title":"MMADHC premature termination codons in the pathogenesis of cobalamin D disorder: Potential of translational readthrough reconstitution.","date":"2021","source":"Molecular genetics and metabolism reports","url":"https://pubmed.ncbi.nlm.nih.gov/33552904","citation_count":4,"is_preprint":false},{"pmid":"34083181","id":"PMC_34083181","title":"Report of rapid diagnosis and precise management of MMADHC-related intracellular cobalamin defect.","date":"2021","source":"BMJ case reports","url":"https://pubmed.ncbi.nlm.nih.gov/34083181","citation_count":1,"is_preprint":false},{"pmid":"41509439","id":"PMC_41509439","title":"Mitochondrial depolarization stabilizes the vitamin B12 chaperone MMADHC in the cytosol to increase MTR activity.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41509439","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.10.687659","title":"Structural insights into cobalamin loading and reactivation of human methionine synthase","date":"2025-11-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.10.687659","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11039,"output_tokens":4212,"usd":0.048148},"stage2":{"model":"claude-opus-4-6","input_tokens":7678,"output_tokens":3104,"usd":0.173985},"total_usd":0.222133,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"MMADHC (cblD gene) was identified as responsible for the cblD defect of vitamin B12 metabolism. The predicted protein contains a putative cobalamin binding motif and a putative mitochondrial targeting sequence with sequence homology to bacterial ATP-binding cassette transporters. Transfection of wild-type MMADHC rescued adenosylcobalamin and methylcobalamin synthesis in cblD fibroblasts, confirming its essential role in intracellular cobalamin metabolism.\",\n      \"method\": \"Microcell-mediated chromosome transfer, genetic mapping, transfection rescue assays in patient fibroblasts, mutant construct analysis\",\n      \"journal\": \"The New England Journal of Medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — functional rescue, multiple mutant constructs, replicated across multiple patients; foundational discovery paper with 122 citations\",\n      \"pmids\": [\"18385497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"The cblD defect can cause three distinct biochemical phenotypes: isolated homocystinuria (cblD-variant 1, deficient methylcobalamin synthesis), isolated methylmalonic aciduria (cblD-variant 2, deficient adenosylcobalamin synthesis), or combined deficiency, demonstrating that MMADHC acts at a branch point affecting both cytosolic (MeCbl) and mitochondrial (AdoCbl) cobalamin pathways.\",\n      \"method\": \"Complementation analysis, cell culture biochemical assays measuring cobalamin derivative synthesis in patient fibroblasts\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — complementation analysis across multiple patient lines replicated in multiple independent labs; 96 citations\",\n      \"pmids\": [\"15292234\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Mutations affecting the N-terminus of MMADHC are associated with methylmalonic aciduria (AdoCbl deficiency), while mutations affecting the C-terminus are associated with homocystinuria (MeCbl deficiency), indicating distinct functional domains within MMADHC for mitochondrial versus cytoplasmic cobalamin trafficking.\",\n      \"method\": \"MMADHC gene sequence analysis in patient DNA, complementation analysis, fibroblast biochemical assays\",\n      \"journal\": \"The Journal of Pediatrics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genotype-phenotype correlation across multiple patients, consistent with functional domain model\",\n      \"pmids\": [\"19058814\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MMADHC physically interacts with MMACHC (cblC protein) both in vitro and in vivo. MMACHC binds cobalamin derivatives with low micromolar affinities, and five putative MMACHC-binding sites on MMADHC were identified by phage display, confirmed by surface plasmon resonance (SPR) and bacterial two-hybrid system.\",\n      \"method\": \"Phage display, surface plasmon resonance (SPR), bacterial two-hybrid system, dynamic light scattering, intrinsic fluorescence\",\n      \"journal\": \"Molecular Genetics and Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vitro and in vivo binding assays; replicated in subsequent studies\",\n      \"pmids\": [\"21071249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"MMADHC has two distinct functional domains: the sequence after Met116 is sufficient for MeCbl synthesis (cytoplasmic function), while the additional sequence between Met62 and Met116 is required for AdoCbl synthesis (mitochondrial function). Improving mitochondrial targeting of MMADHC increased AdoCbl with concomitant decrease in MeCbl, establishing MMADHC as a branch point in intracellular cobalamin trafficking. Mutations N-terminal to Met116 causing cblD-MMA phenotype can produce truncated proteins via downstream reinitiation of translation.\",\n      \"method\": \"Transfection of MMADHC expression constructs with modified mitochondrial leader sequences, stop codon mutations, and downstream reinitiation site mutations into patient fibroblasts; western blot analysis; AdoCbl and MeCbl synthesis assays\",\n      \"journal\": \"Human Molecular Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic mutagenesis across multiple constructs and multiple patient cell lines with quantitative biochemical readouts\",\n      \"pmids\": [\"22156578\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"MMADHC is localized both in the cytoplasm and mitochondria (dual subcellular localization), while MMACHC is exclusively cytoplasmic, as determined by immunofluorescence and subcellular fractionation. This dual localization is consistent with MMADHC functioning as a branch point for vitamin B12 delivery to both cytoplasmic (MeCbl) and mitochondrial (AdoCbl) pathways.\",\n      \"method\": \"Immunofluorescence, subcellular fractionation, retroviral expression of GFP-tagged constructs with functional complementation assays\",\n      \"journal\": \"Molecular Genetics and Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by two independent methods with functional consequence demonstrated by complementation\",\n      \"pmids\": [\"23270877\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Recombinant MMADHC is monomeric, adopts an extended conformation in solution with significant disorder in the N-terminal domain, and does not bind cobalamin directly. The structured C-terminal domain mediates MMACHC interaction with sub-micromolar affinity, stronger than MMACHC self-association.\",\n      \"method\": \"Recombinant protein expression and purification, dynamic light scattering, circular dichroism, clear-native PAGE, phage display, SPR\",\n      \"journal\": \"Molecular Genetics and Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical methods characterizing structure and interaction; no cobalamin binding detected by direct assay\",\n      \"pmids\": [\"22832074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"MMADHC (CblD) functions downstream of MMACHC (CblC) in the cobalamin trafficking pathway. The C-terminal domain of MMADHC interacts with CblC, and this complex forms preferentially under conditions permitting dealkylation of alkylcobalamin by CblC or in the presence of hydroxocobalamin (the dealkylated product), suggesting MMADHC acts as an adapter that partitions the cofactor between AdoCbl and MeCbl assimilation pathways. The N-terminal 115 residues are not required for the CblC–CblD interaction.\",\n      \"method\": \"Isolation of CblC·CblD complex under defined cobalamin substrate conditions, analysis of N-terminal truncation variants, limited proteolysis mapping of stable C-terminal domain, fibroblast dealkylation assays\",\n      \"journal\": \"Biochimie\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal approaches including complex isolation under defined conditions and functional cell assays\",\n      \"pmids\": [\"23415655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mutagenesis mapping identified a region spanning approximately p.R197–D226 of MMADHC as responsible for MeCbl synthesis, with additional flanking regions (p.D226–D246 and p.L259–R266) contributing intermediate phenotypes. C-terminal truncations of more than 20 amino acids produce a combined MMA/HC phenotype, while truncations of 10–20 amino acids produce isolated HC phenotype, defining precise domain boundaries for cytoplasmic versus combined cobalamin trafficking functions.\",\n      \"method\": \"Site-directed mutagenesis (15 missense and 5 C-terminal truncations), transfection rescue assays measuring AdoCbl and MeCbl synthesis in immortalized cblD-MMA/HC patient fibroblasts\",\n      \"journal\": \"Journal of Inherited Metabolic Disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic mutagenesis across 20 constructs with quantitative biochemical readouts in patient cells\",\n      \"pmids\": [\"24722857\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Crystal structure of the MMADHC C-terminal domain at 2.2 Å resolution reveals a modified nitroreductase fold with structural homology to MMACHC despite poor sequence conservation. MMADHC demonstrates no enzymatic activity and is proposed as the first protein to repurpose the nitroreductase fold solely for protein-protein interaction. The MMACHC-MMADHC complex is a 1:1 heterodimer (by SAXS), with the interaction region overlapping the MMACHC-cobalamin binding site, indicating cobalamin is processed by MMACHC prior to interaction with MMADHC. Disease-causing mutations on both proteins disrupt complex formation.\",\n      \"method\": \"X-ray crystallography (2.2 Å), small angle X-ray scattering (SAXS), interaction mapping by mutagenesis, analysis of disease-causing mutations\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus SAXS plus functional mutagenesis in a single study\",\n      \"pmids\": [\"26483544\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The crystal structure of the globular C-terminal domain of human CblD (MMADHC) reveals an α+β fold belonging to the nitro-FMN reductase superfamily, with closest structural relatives being CblC and the activation domain of methionine synthase. CblD enhances oxidation of cob(II)alamin bound to CblC, and disease-causing mutations in CblD impair the kinetics of this reaction, suggesting a functional role in cobalamin redox chemistry at the CblC interface.\",\n      \"method\": \"X-ray crystallography, kinetic assays for cob(II)alamin oxidation, analysis of disease-causing mutant kinetics\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with enzymatic/kinetic assays and disease mutation analysis\",\n      \"pmids\": [\"26364851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MMADHC interacts with methionine synthase (MS) and methionine synthase reductase (MSR) in addition to its known interaction with MMACHC, forming a multiprotein complex (MS, MSR, MMACHC, MMADHC) in the cytoplasm. Disruption of MS or MMACHC expression perturbs interactions among all interactome members. This complex is proposed to shuttle cobalamin efficiently toward MS.\",\n      \"method\": \"Co-immunoprecipitation, DuoLink proximity ligation assays in patient fibroblasts (cblG, cblE, cblC) and HepG2 cells with siRNA knockdown\",\n      \"journal\": \"Biochimica et Biophysica Acta — Molecular Basis of Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal co-IP and proximity ligation from single lab; interaction with MS/MSR not yet independently replicated\",\n      \"pmids\": [\"27771510\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disease-associated premature termination codon (PTC) mutations in MMADHC differentially affect alternative translation initiation site usage, protein abundance, and subcellular localization of MMADHC. Aminoglycoside compounds induced translational PTC readthrough allowing biosynthesis of full-length MMADHC in a PTC-specific manner, suggesting potential for readthrough-based therapy.\",\n      \"method\": \"Characterization of MMADHC protein variants from PTC mutations, subcellular localization analysis, aminoglycoside-induced translational readthrough assays\",\n      \"journal\": \"Molecular Genetics and Metabolism Reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — systematic characterization of multiple variants with functional localization readout from single lab\",\n      \"pmids\": [\"33552904\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"CblD (MMADHC) reacts with CblC-bound cob(II)alamin forming an interprotein thiolato-cobalt coordination complex and transfers the cofactor to methionine synthase, though the precise mechanism of transfer remains to be elucidated.\",\n      \"method\": \"Enzymatic assays described in methods review chapter; biochemical characterization of chaperone activities\",\n      \"journal\": \"Methods in Enzymology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical characterization supporting interprotein thiolato-cobalt complex, but mechanism of transfer incompletely resolved; single review/methods chapter\",\n      \"pmids\": [\"35589192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mitochondrial membrane potential (proton motive force, PMF) collapse stabilizes MMADHC in the cytosol due to mitochondrial import failure, and this cytosol-stabilized MMADHC increases methionine synthase (MTR) levels and activity. MMADHC is normally short-lived; its levels increase upon PMF collapse prior to PINK1 activation, indicating MMADHC is a sensitive sensor linking mitochondrial status to cytosolic one-carbon metabolism.\",\n      \"method\": \"Joint proteomic and RNA-seq screen, subcellular fractionation, LONP1 inhibition, PMF collapse experiments, MTR activity assays across cell types\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, fractionation, activity assays) but preprint not yet peer-reviewed\",\n      \"pmids\": [\"41509439\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures of human methionine synthase (MTR) in apo and cobalamin-bound states show that apo MTR adopts a conformation where the two halves act independently, with the C-half posed to bind cobalamin. AlphaFold predictions validated by interaction studies show MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading into MTR.\",\n      \"method\": \"Cryo-electron microscopy, AlphaFold structure prediction validated by interaction assays\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — cryo-EM structure with interaction validation, but preprint and AlphaFold predictions require independent experimental confirmation\",\n      \"pmids\": [\"bio_10.1101_2025.11.10.687659\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MMADHC (CblD) is a dual-localized (cytoplasmic and mitochondrial) cobalamin trafficking chaperone that acts downstream of MMACHC (CblC) at a branch point in intracellular vitamin B12 metabolism: its C-terminal domain (adopting a nitroreductase fold) interacts with CblC-bound cob(II)alamin to form an interprotein thiolato-cobalt complex and partitions the cofactor between cytosolic methylcobalamin (MeCbl) synthesis for methionine synthase and mitochondrial adenosylcobalamin (AdoCbl) synthesis for methylmalonyl-CoA mutase, with distinct N-terminal and C-terminal regions governing these respective functions, and its stability and cytosolic localization are regulated by mitochondrial membrane potential to modulate methionine synthase activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MMADHC (CblD) is a cobalamin trafficking chaperone that operates at the branch point of intracellular vitamin B12 metabolism, partitioning the cofactor between cytosolic methylcobalamin synthesis for methionine synthase and mitochondrial adenosylcobalamin synthesis for methylmalonyl-CoA mutase [PMID:15292234, PMID:22156578]. Its structured C-terminal domain adopts a nitroreductase fold that mediates a 1:1 interaction with MMACHC (CblC)-bound cob(II)alamin, forming an interprotein thiolato-cobalt complex through which the cofactor is transferred downstream, while the disordered N-terminal region harbors the mitochondrial targeting sequence required for adenosylcobalamin production [PMID:26483544, PMID:26364851, PMID:35589192]. MMADHC is dually localized to the cytoplasm and mitochondria; its cytosolic abundance is regulated by mitochondrial membrane potential, linking mitochondrial status to methionine synthase activity and one-carbon metabolism [PMID:23270877, PMID:41509439]. Biallelic loss-of-function mutations in MMADHC cause the cblD defect of vitamin B12 metabolism, manifesting as isolated methylmalonic aciduria, isolated homocystinuria, or combined disease depending on whether mutations disrupt the N-terminal or C-terminal functional domain [PMID:18385497, PMID:19058814].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Complementation analysis revealed that a single genetic locus (cblD) can produce three distinct biochemical phenotypes—isolated homocystinuria, isolated methylmalonic aciduria, or combined deficiency—establishing that the cblD gene product acts at a branch point directing cobalamin to both cytosolic and mitochondrial pathways.\",\n      \"evidence\": \"Complementation analysis and cobalamin derivative synthesis assays in multiple patient fibroblast lines\",\n      \"pmids\": [\"15292234\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Gene identity not yet determined\", \"Mechanism of branch-point decision unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Positional cloning identified MMADHC as the cblD gene, and wild-type cDNA rescued both adenosylcobalamin and methylcobalamin synthesis in patient cells, while genotype–phenotype correlations showed that N-terminal mutations cause methylmalonic aciduria and C-terminal mutations cause homocystinuria, revealing domain-specific functions.\",\n      \"evidence\": \"Microcell-mediated chromosome transfer, genetic mapping, transfection rescue in patient fibroblasts, and mutation analysis across multiple cblD patients\",\n      \"pmids\": [\"18385497\", \"19058814\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MMADHC binds cobalamin directly was unknown\", \"Structural basis for domain-specific functions unresolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The demonstration that MMADHC physically interacts with MMACHC via multiple binding sites, confirmed by orthogonal methods, established MMADHC as a direct downstream partner of the CblC processing enzyme rather than an independent cobalamin-binding protein.\",\n      \"evidence\": \"Phage display, surface plasmon resonance, and bacterial two-hybrid assays with recombinant proteins\",\n      \"pmids\": [\"21071249\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cobalamin-dependence of the interaction not yet tested\", \"Stoichiometry of the complex unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Systematic domain-swapping experiments defined Met116 as the boundary: sequence downstream of Met116 suffices for methylcobalamin synthesis, while the region between Met62 and Met116 is additionally required for adenosylcobalamin production, with enhanced mitochondrial targeting increasing AdoCbl at the expense of MeCbl—directly demonstrating MMADHC as the branch-point regulator.\",\n      \"evidence\": \"Transfection of modified MMADHC constructs with altered mitochondrial leader sequences and downstream reinitiation sites into patient fibroblasts, with quantitative AdoCbl/MeCbl synthesis assays\",\n      \"pmids\": [\"22156578\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How subcellular partitioning is regulated physiologically was unknown\", \"Whether reinitiation of translation at Met116 is a general mechanism in vivo was unclear\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Biophysical characterization showed MMADHC is a monomer with a disordered N-terminal domain and a structured C-terminal domain that mediates MMACHC binding with sub-micromolar affinity, and importantly that MMADHC does not bind cobalamin directly, confirming it functions as an adaptor rather than a carrier.\",\n      \"evidence\": \"Recombinant protein purification, dynamic light scattering, circular dichroism, clear-native PAGE, SPR; dual localization confirmed by immunofluorescence and subcellular fractionation\",\n      \"pmids\": [\"22832074\", \"23270877\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure not yet available\", \"How cobalamin is transferred from MMACHC through MMADHC to downstream enzymes unresolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Isolation of the MMACHC–MMADHC complex under defined cobalamin conditions showed that complex formation is favored after MMACHC-mediated dealkylation, establishing that MMADHC acts downstream of the CblC processing step and receives already-dealkylated cobalamin.\",\n      \"evidence\": \"Complex isolation under defined cobalamin substrate conditions, limited proteolysis, fibroblast dealkylation assays\",\n      \"pmids\": [\"23415655\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Fate of cofactor after MMADHC interaction still unresolved\", \"Molecular basis for preferential complex formation with dealkylated cobalamin unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Fine-resolution mutagenesis mapped the MeCbl-specific function to residues ~R197–D226 and showed that progressive C-terminal truncations shift the phenotype from isolated homocystinuria to combined MMA/HC deficiency, defining precise domain boundaries for cytoplasmic cobalamin trafficking.\",\n      \"evidence\": \"15 missense and 5 C-terminal truncation constructs tested by transfection rescue in immortalized cblD fibroblasts\",\n      \"pmids\": [\"24722857\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural interpretation of how these residues participate in MeCbl-specific function\", \"Residues required for mitochondrial AdoCbl function not systematically mapped at this resolution\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Crystal structures of the MMADHC C-terminal domain revealed a nitroreductase fold homologous to MMACHC despite negligible sequence similarity, and SAXS confirmed a 1:1 heterodimer with MMACHC where the interaction surface overlaps the cobalamin-binding site; kinetic assays showed CblD enhances oxidation of CblC-bound cob(II)alamin, with disease mutations impairing this reaction.\",\n      \"evidence\": \"X-ray crystallography at 2.2 Å resolution, SAXS, mutagenesis of disease-causing variants, kinetic assays for cob(II)alamin oxidation\",\n      \"pmids\": [\"26483544\", \"26364851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of the full-length MMADHC including the disordered N-terminal domain\", \"Structural basis for how cobalamin is handed off to methionine synthase or mitochondrial pathway unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Co-immunoprecipitation and proximity ligation assays identified MMADHC as part of a cytoplasmic multiprotein complex with methionine synthase, methionine synthase reductase, and MMACHC, suggesting a channeling mechanism for cobalamin delivery to methionine synthase.\",\n      \"evidence\": \"Co-IP and DuoLink proximity ligation in patient fibroblasts and HepG2 cells with siRNA knockdown\",\n      \"pmids\": [\"27771510\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Interaction with MS/MSR not independently replicated\", \"Stoichiometry and architecture of the multiprotein complex unresolved\", \"Whether the complex is constitutive or regulated is unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Biochemical characterization confirmed that MMADHC forms an interprotein thiolato-cobalt coordination complex with MMACHC-bound cob(II)alamin and can transfer the cofactor to methionine synthase, establishing the chemical nature of the hand-off intermediate.\",\n      \"evidence\": \"Enzymatic assays characterizing chaperone activities of the CblC–CblD complex\",\n      \"pmids\": [\"35589192\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Precise mechanism of cofactor transfer to methionine synthase not elucidated\", \"Whether a similar coordination complex forms during mitochondrial AdoCbl delivery is unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proteomic and functional studies showed that mitochondrial membrane potential collapse stabilizes MMADHC in the cytosol (due to import failure), which in turn increases methionine synthase protein levels and activity—revealing MMADHC as a sensor linking mitochondrial status to cytosolic one-carbon metabolism. Separately, cryo-EM structures of apo methionine synthase showed MMADHC interacts with the C-half of apo MTR to facilitate cobalamin loading.\",\n      \"evidence\": \"Joint proteomic/RNA-seq screen, subcellular fractionation, PMF collapse experiments, MTR activity assays (preprint); cryo-EM of MTR with AlphaFold-guided interaction mapping (preprint)\",\n      \"pmids\": [\"41509439\", \"bio_10.1101_2025.11.10.687659\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Both studies are preprints awaiting peer review\", \"Structural details of MMADHC–apo MTR interface require experimental validation beyond AlphaFold\", \"Whether MMADHC sensing of mitochondrial status is relevant in vivo under physiological stress is untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism by which MMADHC partitions cobalamin between the mitochondrial adenosylcobalamin and cytosolic methylcobalamin pathways—including the signals governing this decision, the structural basis for cofactor hand-off to methionine synthase and to the mitochondrial import machinery, and the physiological regulation of MMADHC partitioning in vivo—remains incompletely understood.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structure of full-length MMADHC or its complex with a downstream target\", \"Mechanism of cobalamin transfer to methylmalonyl-CoA mutase in mitochondria uncharacterized\", \"In vivo regulation of the branch-point decision is unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [6, 7, 9, 13]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [10, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [4, 5, 14]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 1, 4, 8]}\n    ],\n    \"complexes\": [\n      \"MMACHC-MMADHC heterodimer\"\n    ],\n    \"partners\": [\n      \"MMACHC\",\n      \"MTR\",\n      \"MTRR\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}